EUVIMEDEUVIMED entdecken
Open Access

Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites

Alyssa M Lantz iD, Flavia Kiweewa Matovu, Reilly Johnson, Esther Isingel, Rita Nakalega, Samuel Kabwigu, Mags E Beksinska, Melanie R Nicol iD

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Alyssa M Lantz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis. Hauptthemen laut MEDLINE: Tenofovir, Lamivudine, HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We previously reported the effect of contraception on cervical tenofovir concentrations in Ugandan women with human immunodeficiency virus (HIV). Here we explored the role of cervicovaginal cytokines and drug metabolizing enzymes and transporters (DMETs) to elucidate female genital tract (FGT) drug disposition in a Ugandan cohort.

Methods

Cervicovaginal fluid and cervical biopsies were collected from Ugandan women with HIV receiving tenofovir/lamivudine-based therapy and intramuscular depot medroxyprogesterone acetate (n = 25), copper intrauterine device (cuIUD; n = 12), or condoms (n = 13) as contraception. Cytokines were measured in cervicovaginal fluid (CVF). Ectocervical tenofovir diphosphate (TFVdp), lamivudine triphosphate (3TCtp), and deoxyadenosine triphosphate (dATP)/deoxycytidine triphosphate (dCTP) concentrations and immune marker/DMET gene expression were measured in cervical biopsies.

Results

Cervical 3TCtp was not correlated with any CVF cytokines. Cervical TFVdp was correlated with IL-10, IL-7, and IL-17 in CVF. CCR5 mRNA expression in cervical biopsies was higher in cuIUD users versus condom users. Using multivariable linear regression, CVF IL-17, tissue dATP, plasma estradiol, and plasma tenofovir were all significant predictors of cervical TFVdp. Tissue dCTP and plasma lamivudine were significant predictors of cervical 3TCtp.

Conclusions

TFVdp concentrations in cervix appear to be influenced by local inflammation. In contrast, 3TCtp FGT exposure was not affected by genital inflammation or DMETs. CuIUD users have more immune cells present, which may in turn influence local TFVdp disposition. Main Finding We investigated changes in tenofovir diphosphate and lamivudine triphosphate due to the microbiome and inflammation. While lamivudine triphosphate was not affected by either, tenofovir diphosphate appeared to be affected by local inflammation. Specifically, Th17 cells may influence tenofovir disposition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TenofovirLamivudineHIV InfectionsAnti-HIV AgentsCytokinesHumansFemaleAdultCervix UteriUgandaYoung AdultVagina

Stichwörter der Autor:innen

contraceptionfemale genital tractinflammationlamivudinetenofovir

Substanzen

TenofovirLamivudineAnti-HIV AgentsCytokines

Autor:innen und Institutionen

  • Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis.
  • Makerere University-John Hopkins University Research Collaboration, Kampala Uganda.
  • College of Health Sciences, Makerere University, Kampala, Uganda.
  • Wits MatCH Research Unit, Department of Obstetrics and Gynecology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

ORCID-Profile: Alyssa M Lantz, Melanie R Nicol

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIH HHS

Zitieren

APA

Lantz, A. M., Kiweewa Matovu, F., Johnson, R., Isingel, E., Nakalega, R., Kabwigu, S., Beksinska, M. E., & Nicol, M. R. (2024). Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae372

Vancouver

Lantz AM, Kiweewa Matovu F, Johnson R, Isingel E, Nakalega R, Kabwigu S, et al. Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae372

BibTeX
@article{Lantz2024,
  author = {Lantz, Alyssa M and Kiweewa Matovu, Flavia and Johnson, Reilly and Isingel, Esther and Nakalega, Rita and Kabwigu, Samuel and Beksinska, Mags E and Nicol, Melanie R},
  title = {Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae372}
}
Kostenlos starten →